Inspection Readiness and Regulatory Quality Management | MyTrial Academy
Inspection Readiness and Regulatory Quality Management
Inspection readiness is not a project you start when the FDA sends a notification letter. It is a continuous state -- the natural consequence of doing everything in Courses 2 through 5 well. This course teaches you to build, maintain, and lead a site-wide inspection readiness program. It covers mock inspections, gap analyses, CAPA management, and the specific preparation required when a regulatory authority or sponsor audit actually occurs. But it frames all of this within a quality management system that extends beyond inspections: the ongoing program that ensures the site's regulatory operations meet the standard every day, not just on inspection day.
CAPA gets its own substantial treatment here because the RC is the person who drives corrective and preventive action in the regulatory domain. Not the CRC who documents a finding. Not the PI who signs off on the response. The RC who designs the correction, implements the prevention, and tracks the effectiveness. CAPA at the portfolio level is a different competency than CAPA at the study level.
Studied within the Regulatory Coordinator track. One payment of $179 USD covers all seven courses and the certificate.
Modules
7
Lessons
27
Knowledge checks
7
Study time
~about 10h
Final exam50 questions · 80% to pass · 90 minutes · up to 3 attemptsICH E6(R3)Intermediate
What you will be able to do
01Design a site-wide inspection readiness program that maintains continuous compliance rather than event-driven preparation (ICH E6(R3) Annex 1, Sections 3.10-3.11)
02Conduct gap analyses and mock inspections that identify regulatory vulnerabilities before external auditors or inspectors discover them
03Lead the site's regulatory CAPA process from root cause analysis through corrective action implementation, preventive action design, and effectiveness verification
04Manage the site's response during sponsor audits and regulatory authority inspections, including document preparation, staff preparation, and real-time coordination
05Implement a regulatory quality management system at the site level that integrates quality oversight into routine operations per ICH E6(R3) Annex 1, Section 3.10
06Evaluate inspection findings, FDA 483 observations, and audit reports to determine appropriate scope and depth of corrective action
Seven modules,one final exam.
Seven modules and twenty-seven lessons, each module closing with a knowledge check, and a final exam to complete the course.
A knowledge check closes every module
FreeThree lessons are open to read now
Pass the final exam at 80% to complete the course
IInspection readiness as a continuous state4 lessons · knowledge check1 free lesson
1.1Why reactive inspection preparation fails: the gap between 'looking ready' and 'being ready'Read free
1.2The quality management foundation: ICH E6(R3) Section 3.10 as the framework for continuous readiness
1.3Defining 'inspection-ready' for your site: standards, metrics, and the gap between aspiration and reality
1.4The RC as quality leader: why inspection readiness ownership belongs to the regulatory function
IIGap analysis and self-inspection4 lessons · knowledge check
2.1Conducting a regulatory gap analysis: methodology, scope, and documentation
2.2Mock inspections: designing exercises that simulate real inspection conditions
2.3Staff interviews and process observation: identifying gaps between SOPs and actual practice
2.4Prioritizing findings: risk-based approaches to gap remediation
IIICAPA in the regulatory domain4 lessons · knowledge check1 free lesson
3.1Root cause analysis for regulatory findings: getting past the symptom to the system failureRead free
3.2Designing corrective actions that actually correct: scope, specificity, and accountability
3.3Preventive actions: changing the system so the problem cannot recur
3.4Effectiveness verification: how to determine whether your CAPA actually worked
6.1Portfolio compliance dashboards: maintaining visibility into regulatory status across all active studies
6.2Cross-study trend analysis: identifying systemic issues that individual study reviews miss
6.3Risk-proportionate quality oversight: allocating monitoring and quality resources based on study complexity and compliance history
VIIRegulatory communication deliverables: quality and compliance4 lessons · knowledge check
7.1Writing effective CAPA plans: precision, accountability, and measurability
7.2Inspection response communications: meeting regulatory authority, institutional, and sponsor expectations
7.3Quality status reports: communicating regulatory health to site leadership
7.4Building a quality communication culture: making regulatory quality visible and valued
Final Exam: Inspection Readiness and Regulatory Quality Management50 questions · 80% to pass · 90 minutes · up to 3 attempts
Read three lessonsbefore you enroll.
Each is open now, exactly as enrolled learners read them. Every lesson in the course is written, cited and narrated the same way.
Module I · Lesson 122 min
Why reactive inspection preparation fails: the gap between 'looking ready' and 'being ready'
Dissects the fundamental failure mode of reactive inspection preparation and introduces the distinction between surface-level and substantive readiness.
Root cause analysis for regulatory findings: getting past the symptom to the system failure
Teaches structured root cause analysis methodologies that drive past proximate causes to systemic process and design failures across multiple studies -- because corrective actions aimed at symptoms guarantee recurrence.
Responding to FDA 483 observations and international inspection findings: regulatory, institutional, and sponsor notification requirements
Covers the FDA 483 response process in depth and provides substantive treatment of key procedural differences when the inspecting authority is EMA, MHRA, or Health Canada -- because an RC at a multi-national site or a site participating in global trials will encounter non-FDA inspections. Addresses regulatory, institutional, and sponsor notification obligations.
Each point links back to its section of the guideline.
Narrated end to end
Listen when you can’t sit down to read.
Saves your place
Pick up exactly where you stopped.
Studied as part ofthe Regulatory Coordinator track.
Inspection Readiness and Regulatory Quality Management is the sixth of seven courses in the Regulatory Coordinator track. It is not sold on its own: one enrollment opens every course, every final exam and the certificate.
Regulatory Coordinator
Portfolio-level regulatory operations training for clinical research sites
Courses
7
Lessons
180
Study time
~67 h
Pass every final exam and your credential is issued, with the printable certificate included.
$179 USDOne payment for the whole track. Access does not expire.
How it is enrolled in, what the exam asks, and what you can read first.
Can I take this course on its own?
Not separately. Inspection Readiness and Regulatory Quality Management is the sixth course in the Regulatory Coordinator track, and the track is enrolled in as one: all seven courses, every final exam and the certificate, for one payment of $179 USD.
What does the final exam ask?
Fifty questions in 90 minutes, with 80% needed to pass, and up to three attempts. Each module also closes with a knowledge check.
Can I read any of it before I enroll?
Yes. Three lessons are open now: “Why reactive inspection preparation fails: the gap between 'looking ready' and 'being ready'”, “Root cause analysis for regulatory findings: getting past the symptom to the system failure” and “Responding to FDA 483 observations and international inspection findings: regulatory, institutional, and sponsor notification requirements”.
Is it aligned to ICH E6(R3)?
Yes. The course works from ICH E6(R3).
Does course access expire?
No. Access is yours for good. The Regulatory Coordinator credential the track awards is valid for two years.
Study Inspection Readiness and Regulatory Quality Management,within the Regulatory Coordinator track.
One enrollment opens all seven courses, every final exam and the certificate. Course access does not expire.
Not separately. Inspection Readiness and Regulatory Quality Management is the sixth course in the Regulatory Coordinator track, and the track is enrolled in as one: all seven courses, every final exam and the certificate, for one payment of $179 USD.
Can I read any of it before I enroll?
Yes. Three lessons are open now: “Why reactive inspection preparation fails: the gap between 'looking ready' and 'being ready'”, “Root cause analysis for regulatory findings: getting past the symptom to the system failure” and “Responding to FDA 483 observations and international inspection findings: regulatory, institutional, and sponsor notification requirements”.
Read three lessonsbefore you enroll.
Each is open now, exactly as enrolled learners read them. Every lesson in the course is written, cited and narrated the same way.
Module I · Lesson 122 min
Why reactive inspection preparation fails: the gap between 'looking ready' and 'being ready'
Dissects the fundamental failure mode of reactive inspection preparation and introduces the distinction between surface-level and substantive readiness.
Root cause analysis for regulatory findings: getting past the symptom to the system failure
Teaches structured root cause analysis methodologies that drive past proximate causes to systemic process and design failures across multiple studies -- because corrective actions aimed at symptoms guarantee recurrence.
Responding to FDA 483 observations and international inspection findings: regulatory, institutional, and sponsor notification requirements
Covers the FDA 483 response process in depth and provides substantive treatment of key procedural differences when the inspecting authority is EMA, MHRA, or Health Canada -- because an RC at a multi-national site or a site participating in global trials will encounter non-FDA inspections. Addresses regulatory, institutional, and sponsor notification obligations.